These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 2302644)

  • 41. Human immunodeficiency virus infection in a Dublin general practice.
    Bury G; O'Kelly F
    J R Coll Gen Pract; 1989 Mar; 39(320):101-3. PubMed ID: 2555484
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AIDS and intravenous drug use: future directions for community-based prevention research.
    NIDA Res Monogr; 1990; 93():1-299. PubMed ID: 2300135
    [No Abstract]   [Full Text] [Related]  

  • 43. Accessing intravenous drug users via the health care system.
    Evans PE
    NIDA Res Monogr; 1990; 93():277-87. PubMed ID: 2300145
    [No Abstract]   [Full Text] [Related]  

  • 44. HIV seropositivity of needles from shooting galleries in south Florida.
    Chitwood DD; McCoy CB; Inciardi JA; McBride DC; Comerford M; Trapido E; McCoy HV; Page JB; Griffin J; Fletcher MA
    Am J Public Health; 1990 Feb; 80(2):150-2. PubMed ID: 2297056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Strategies for enhancing existing studies of the natural history of HIV-1 infection among drug users.
    Chitwood DD; Comerford M; Trapido EJ
    NIDA Res Monogr; 1991; 109():9-28. PubMed ID: 1753993
    [No Abstract]   [Full Text] [Related]  

  • 46. AIDS prevention for intravenous drug users in the community: street-based education and risk behavior.
    Watters JK; Downing M; Case P; Lorvick J; Cheng YT; Fergusson B
    Am J Community Psychol; 1990 Aug; 18(4):587-96. PubMed ID: 2075893
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expanding the focus of human immunodeficiency virus prevention in the 1990s.
    Rango NA; Rampolla M
    N Y State J Med; 1990 Mar; 90(3):116-9. PubMed ID: 2314713
    [No Abstract]   [Full Text] [Related]  

  • 48. PHS grants for minority group HIV infection education and prevention efforts.
    Bowles J; Robinson WA
    Public Health Rep; 1989; 104(6):552-9. PubMed ID: 2511587
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NJSNA position statement on needle exchange.
    N J Nurse; 1994; 24(1):4. PubMed ID: 8115247
    [No Abstract]   [Full Text] [Related]  

  • 50. [Infectious diseases in intravenous drug abuse patients].
    Leusden RP; Stark K
    Z Arztl Fortbild (Jena); 1992 Jul; 86(14):709-16. PubMed ID: 1529622
    [No Abstract]   [Full Text] [Related]  

  • 51. Risk factors for HIV infection among drug users in Yunnan province, China: association with intravenous drug use and protective effect of boiling reusable needles and syringes.
    Xia M; Kreiss JK; Holmes KK
    AIDS; 1994 Dec; 8(12):1701-6. PubMed ID: 7888119
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HIV epidemic in Punjab, India: time trends over a decade.
    Sehgal S
    Bull World Health Organ; 1998; 76(5):509-13. PubMed ID: 9868842
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Harm reduction: a public health response to the AIDS epidemic among injecting drug users.
    Des Jarlais DC; Friedman SR; Ward TP
    Annu Rev Public Health; 1993; 14():413-50. PubMed ID: 8323596
    [No Abstract]   [Full Text] [Related]  

  • 54. Needle exchange project recommended for New Jersey.
    Wurmser T
    N J Nurse; 1993; 23(1):5. PubMed ID: 8433924
    [No Abstract]   [Full Text] [Related]  

  • 55. Syringe distribution to injection drug users for prevention of HIV infection: opinions and practices of health care providers in New York City.
    Coffin PO; Fuller C; Blaney S; Vadnai L; Miller S; Vlahov D
    Clin Infect Dis; 2004 Feb; 38(3):438-41. PubMed ID: 14727219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intravenous drug abuse and AIDS transmission: Federal and State laws regulating needle availability.
    Pascal CB
    NIDA Res Monogr; 1988; 80():119-36. PubMed ID: 3136338
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Risk reduction and intravenous drug use abstinence in patients with HIV infection. The SEROCO group].
    Meyer L; Wade A; Persoz A; Boué F; Dellamonica P; Caroli-Bosc C; Carré N
    Rev Epidemiol Sante Publique; 1998 Feb; 46(1):34-9. PubMed ID: 9533232
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The limitations of the concept of needle sharing: the practice of frontloading.
    Grund JP; Kaplan CD; Adriaans NF; Blanken P; Huisman J
    AIDS; 1990 Aug; 4(8):819-21. PubMed ID: 2261141
    [No Abstract]   [Full Text] [Related]  

  • 59. [Future scenarios of HIV-AIDS: from the "event" disease to diffuse chronicity. From the moral stigma to the central zones of social vulnerability].
    Conde Gutiérrez F
    Rev Esp Salud Publica; 1997; 71(1):1-7. PubMed ID: 9147793
    [No Abstract]   [Full Text] [Related]  

  • 60. The HIV dilemma.
    Batey R
    Med J Aust; 1990 Sep; 153(5):299-300. PubMed ID: 2392076
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.